PDL BioPharma, Inc. Beginning Cash

Beginning Cash of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Beginning Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Beginning Cash for the quarter ending June 29, 2020 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Beginning Cash decreased by NaN%
  • Annual Beginning Cash for 2019 was $395 Million (a -25.16% decrease from previous year)
  • Annual Beginning Cash for 2018 was $527 Million (a 258.31% increase from previous year)
  • Annual Beginning Cash for 2017 was $147 Million (a -32.77% decrease from previous year)
  • Twelve month Beginning Cash ending June 29, 2020 was $193 Million (a 0.0% decrease compared to previous quarter)
  • Twelve month trailing Beginning Cash decreased by -50.97% year-over-year
Trailing Beginning Cash for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$193 Million $193 Million $395 Million $395 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Beginning Cash of PDL BioPharma, Inc.

Most recent Beginning Cashof PDLI including historical data for past 10 years.

Interactive Chart of Beginning Cash of PDL BioPharma, Inc.

PDL BioPharma, Inc. Beginning Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.0 $193.45
2019 $0.0 $0.0 $0.0 $394.59 $394.59
2018 $0.0 $0.0 $0.0 $527.27 $527.27
2017 $0.0 $0.0 $0.0 $147.15 $147.15
2016 $0.0 $0.0 $0.0 $218.88 $218.88
2015 $0.0 $0.0 $0.0 $291.38 $291.38
2014 $0.0 $0.0 $0.0 $94.3 $94.3
2013 $0.0 $0.0 $0.0 $131.21 $131.21
2012 $0.0 $0.0 $0.0 $168.54 $168.54
2011 $0.0 $0.0 $0.0 $211.57 $211.57
2010 $0.0 $0.0 $0.0 $303.23

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.